Shiv Sarin to Hepatitis B virus
This is a "connection" page, showing publications Shiv Sarin has written about Hepatitis B virus.
Connection Strength
1.040
-
A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B. Saudi J Gastroenterol. 2019 Sep-Oct; 25(5):319-326.
Score: 0.462
-
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region. Hepatol Int. 2019 Nov; 13(6):695-705.
Score: 0.117
-
Global microRNA expression profiling in the liver biopsies of hepatitis B virus-infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury. Hepatology. 2018 05; 67(5):1695-1709.
Score: 0.105
-
An RNAi-based high-throughput screening assay to identify small molecule inhibitors of hepatitis B virus replication. J Biol Chem. 2017 07 28; 292(30):12577-12588.
Score: 0.099
-
Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients. Liver Int. 2018 01; 38(1):38-49.
Score: 0.099
-
Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS One. 2014; 9(3):e91745.
Score: 0.079
-
Profile of asymptomatic chronic HBV infection in India. Indian J Med Res. 2002 Aug; 116:50-7.
Score: 0.035
-
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. Hepatol Int. 2019 Nov; 13(6):649-661.
Score: 0.029
-
Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011 Mar; 53(3):774-80.
Score: 0.016